Navigation Links
Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma
Date:9/2/2008

- First of three ongoing randomized chemotherapy combination trials to

evaluate HGS-ETR1 in the treatment of specific cancers -

ROCKVILLE, Md., Sept. 2 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today reported initial topline results from an ongoing randomized Phase 2 clinical trial of its TRAIL receptor antibody HGS-ETR1 (mapatumumab) in combination with bortezomib (Velcade) in patients with advanced multiple myeloma. The initial data from the multiple myeloma study show that HGS-ETR1 was well tolerated and suggest that disease response was comparable for this combination vs. bortezomib alone.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"We continue to be excited about HGS-ETR1 and our TRAIL receptor antibody program," said David C. Stump, M.D., Executive Vice President, Research and Development, HGS. "The TRAIL-mediated apoptosis pathway is an important area of cancer research, and agonistic antibodies to this target offer great promise. HGS-ETR1 is the most advanced of any product in development that targets this pathway, with three randomized chemotherapy combination trials currently ongoing to evaluate its potential for the treatment of specific cancers. We look forward to maturing results from all three trials. Taken together, these results will inform our decision on whether to advance HGS- ETR1 to Phase 3 development."

Key Findings

The trial in advanced multiple myeloma is a randomized, multi-center, open-label Phase 2 study to evaluate the efficacy and safety of HGS-ETR1 (mapatumumab) in combination with bortezomib in these patients. 104 patients are being treat
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...EWYORK,Nov.25/PRNewswire/--Reportlinker.comannounc...logue: ,, MammographyEquipment-AGlobalMarketP...164330/Mammography-Equipment---A-Global-Market-Per...inindustrializedaswellasdevelopingnationsisaprinci...lobally,escalatingawarenessaboutbreastcancerhasall...
(Date:11/25/2009)...ANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVasive,Inc...elopingproductsforminimallydisruptivesurgicaltreat...erencecallonMonday,November30,2009,at5:30p.m.ET/2:...relativetoreimbursementfortheCompany,sproductsandw...estionandanswersession.Thedial-innumbersare1-877-4...
(Date:11/25/2009)...ELFT,TheNetherlandsandJOHANNESBURG,November25/PRNe...dPyxisDiscoveryannouncedtoday,thattheyhavesignedac...,services. , Pyxis,sworldclasscomputationalch...iThemba,sservicedivisiontoprovidemedicinaland,synt...xis,internationalclientnetwork.iThembaPharmaceuti...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Ross University School of Medicine Expands Clinical Rotations in Miami 47868 1Ross University School of Medicine Expands Clinical Rotations in Miami 47868 2Entrepreneur Magazine 3A MxSecure Among 100 26quot 3BBrilliant Companies 26quot 3B 47866 1Entrepreneur Magazine 3A MxSecure Among 100 26quot 3BBrilliant Companies 26quot 3B 47866 2Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients 47864 1Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients 47864 2Text Messaging Medication Reminders Significantly Reduces Organ Rejection in Pediatric Liver Transplant Recipients 47864 3
...arlo brings predictability to whole range ...AYLAND, Mass., Sept. 4 Tourtellotte Solutions, a,...hain software for the,biopharmaceutical, retail, a...release of its tcVisualize(TM) 3.0 clinical trial ...e software now offers wide support for variable,do...
...Incorporated,(Nasdaq: VPHM ) today announced that...fficer and chief financial officer of ViroPharma, ...althcare Conference at 8:00 A.M. ET on,Wednesday, ... the Four,Seasons Hotel in Boston, MA. Mr. Milano...ewsmakers,in the Biotech Industry Conference at 1:...
Other Medicine Technology:Tourtellotte Solutions Blazes Trail with New Release of Clinical Trial Supply Chain Simulator 2ViroPharma to Present at Three Upcoming Healthcare Conferences 2
(Date:11/26/2009)... Ennis & Ennis, P.A. is offer... users of Yaz and Yasmin birth control pills who h...ry Embolism, Stroke, Heart Attack or other related...Women can call toll free at 1-800-856-6405 or go t....com and fill out an online case evaluation form....
(Date:11/25/2009)...TORONTO,Nov.25/PRNewswire/-SentinelleMedicalInc.,a...alizationsoftwarelaunchesasuiteofnewleadingedgecli...areplatformatthisyear,sRadiologicalSocietyofNorthA...09(Booth5800,HallA).Theapplicationsleveragetheuniq...zedMRIimagingcoilsandsupportmultipleimagingmodalit...
(Date:11/25/2009)... BroadPoliticalEndorsements,Business,andPressJoinE...ire-USNewswire/--Onceagain,theNationalBipolarFound...nendorsingtheir"Safe,tilStable"program,whichisnowb...rbipolardisorder.Today,theNationalBipolarFoundatio...ssPriorityMailfromtheLt.GovernorofLouisianaMitchLa...
(Date:11/25/2009)...y follow-up period was too short to draw definite ..., Nov. 25 (HealthDay News) -- In diabetic patients...be no difference in outcomes at one year whether p... stenting, British researchers report. , Bypass...tic patients with coronary artery disease. However...
(Date:11/25/2009)...positive note, CDC sees few signs of trouble with ...5 (HealthDay News) -- The ongoing H1N1 swine flu p... pneumonias among younger patients, a U.S. health ...crease in serious pneumococcal infections around t...tional Center for Immunization and Respiratory Dis...
Breaking Medicine News(10 mins):Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4
...ing Patients Based on Genotype May Increase Effica...ry the wild-type gene required for tamoxifen metab...taking tamoxifen or an aromatase inhibitor, accord...ifferent variants of the CYP2D6 gene metabolize ...
...cated memory manipulation ethically sound? And per...the decision to deliver such a treatment: patient ...sor, is seeking answers to these questions in her ...nal, non-surgical procedure called targeted memory...
...eart Association advocates call on lawmakers to su...29 With risk factors for,heart disease and stroke...troke survivors and researchers from across the co...ional,Lobby Day, You,re the Cure on the Hill 2008,...
...ril 29 The American Humane,Association today anno...-Animal Bond Division, to further enhance and expa...cations and the benefits of the,connection between...ldren,s Division, both of which have been in,exist...
...elease is available in German . ,,, Leipzig. U...y dwellers in the Czech Republic and Poland did no...perties and demolitions. In East Central Europe, t...the Helmholtz Centre for Environmental Research (U...
...-wide, web-based solution will improve care and en...orida locations, TAMPA, Fla., April 29 To achiev... to enhance patient care delivery and,business off...alth Records and Intergy by Sage Practice Manageme...
Other Medicine News:Health News:Other highlights in the April 29 JNCI 2Health News:Other highlights in the April 29 JNCI 3Health News:Other highlights in the April 29 JNCI 4Health News:Other highlights in the April 29 JNCI 5Health News:Other highlights in the April 29 JNCI 6Health News:Moral philosopher questions memory manipulation 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 3Health News:American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Women's Shelters 2Health News:American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Women's Shelters 3Health News:American Humane Forms Human-Animal Bond Division, Including Animal-Assisted Therapy, Humane Ed and Pets & Women's Shelters 4Health News:Shrinkage and aging are Europe-wide challenges 2Health News:Shrinkage and aging are Europe-wide challenges 3Health News:Shrinkage and aging are Europe-wide challenges 4Health News:Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records 2Health News:Florida Cardiology Chooses Intergy by Sage to Integrate Practice Management and Electronic Health Records 3
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: